A programme of work to develop and evaluate an intervention to promote activity and independence for people with early dementia and mild cognitive impairment

ottingham University Hospitals Trust0 sites60 target enrollmentAugust 31, 2016

Overview

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29468084 protocol 2018 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/29436253 development of the intervention 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31842828 results (added 18/12/2019) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35677674/ Social return on investment results (added 10/06/2022)

Registry

who.int

Start Date

August 31, 2016

End Date

March 1, 2019

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Sponsor

ottingham University Hospitals Trust

•1\.1\. Health care staff with professional knowledge and expertise on falls, dementia, or related health conditions
•1\.2\. The PPI focus group will be recruited from members of a established dementia\-specialist PPI group
•1\.3\. Patient and carer focus group, will be a group of people with mild dementia, meeting the inclusion criteria for the feasibility trial (recruited via Alzheimer Society)
•2\. WP2: Uptake and adherence focus group. A group of people with mild dementia, meeting the inclusion criteria for the feasibility trial, and their family carers (recruited via Alzheimer Society)
•3\. WP3 feasibility trial:
•3\.1 Age 65 or over (no maximum)
•3\.2\. A diagnosis of dementia or MCI (of any subtype)
•3\.3\. Able to walk without human help
•3\.4\. Able to communicate in English, with a translator if necessary
•3\.5\. Able to see, hear and have dexterity sufficiently to perform neuropsychological tests

•1\. WP 1\-2: There will be no specific exclusion criteria, but people recruited are likely to be those who would otherwise have been appropriate for the feasibility trial
•2\.1\. Co\-morbidity preventing participation (e.g. severe breathlessness, pain, psychosis, Parkinson’s or other severe neurological disease)
•2\.2\. Life expectancy of less than 1 year
•2\.3\. Likely to be unable to undertake the intervention regularly (e.g. planned elective surgery, planning to move away or commitments elsewhere)
•3\. WP4 participants will be drawn from those taking part in WP3, exclusion criteria will be the same